Agenda
February 24, 2026
Conference registration will remain open throughout the entirety of the conference.
Biocom’s Global Partnering & Investor Conference utilizes partneringONE to facilitate one-on-one meetings between conference attendees. The partnering system is now open. Approved registrants can update their profiles, identify potential partners and request meetings with fellow attendees.
John Connolly, Ph.D.
Chief Scientific Officer, Parker Institute for Cancer Immunotherapy
Giulio Draetta, M.D., Ph.D.
Former Chief Scientific Officer, University of Texas MD Anderson Cancer Center
Amy DuRoss
Mayo Venture Partner, Mayo Clinic
Nina Kjellson
General Partner, Canaan Partners
Peter Schultz, Ph.D.
President, CEO & Professor of Chemistry, Scripps Research
Our Global Partnering & Investor Conference will include multi-track presentation sessions, which provide a stage for emerging life science companies to showcase their latest innovations and gain additional exposure to investors and potential strategic partners in attendance.
Paul Biondi
Managing Partner, Flagship Pioneering
Niels Emmerich, Ph.D.
Vice President, Search and Evaluation & Global Alliances, AbbVie
Judith Li
Partner, Lilly Asia Ventures
Mathai Mammen, M.D., Ph.D.
Chairman, CEO & President, Parabilis Medicines
Ken Song, M.D.
Chairman, President & CEO, Candid Therapeutics
Nancy Thornberry
Founding CEO & Chair, R&D, Kallyope
Biocom invites you to a welcome reception at The Lodge at Torrey Pines. This reception provides an excellent opportunity to network with conference attendees and speakers, as well as gain exclusive access to the delegates visiting San Diego from all over the globe.
February 25, 2026
We invite you to join us for a networking breakfast before our first session of the day. We encourage you to arrive by 8:00 a.m. to ensure you get a seat in time for the sessions kicking off at 8:15 a.m.
Conference registration will remain open throughout the entirety of the conference.
Biocom’s Global Partnering & Investor Conference utilizes partneringONE to facilitate one-on-one meetings between conference attendees. The partnering system is now open. Approved registrants can update their profiles, identify potential partners and request meetings with fellow attendees.
Jason Hafler, Ph.D.
Managing Director, Sanofi Ventures
Jim Krenn
Partner & Co-Chair, Emerging Companies and Venture Capital Group, Morrison & Foerster
Tim Luker, Ph.D.
Vice President, Lilly Ventures, West Coast USA Head, Corp BD, Eli Lilly
Detlev Mennerich, Ph.D.
Global Head, Boehringer Ingelheim Venture Fund
Lior Teitelbaum, M.Sc.
Principal, Venture Investments, Johnson & Johnson Innovation – JJDC
Chen Yu, M.D.
Founder & Managing Partner, TCGX
Our Global Partnering & Investor Conference will include multi-track presentation sessions, which provide a stage for emerging life science companies to showcase their latest innovations and gain additional exposure to investors and potential strategic partners in attendance.
Stacy Feld, J.D.
Global Head, External Scientific Innovation, Johnson & Johnson Innovation
Nikhil Mutyal, Ph.D.
Head of Search & Evaluation, Respiratory & Immunology, AstraZeneca
Jeremy Quirk
VP BD&L Commercial Portfolio, GSK
Issei Tsukamoto, Ph.D.
SVP, Head of Business Development, Astellas Pharma
Adam Welland
Counsel, Technology & Life Science Transactions, Sidley Austin
Our Global Partnering & Investor Conference will include multi-track presentation sessions, which provide a stage for emerging life science companies to showcase their latest innovations and gain additional exposure to investors and potential strategic partners in attendance.
Unwind from a day of enriching sessions and one-on-one partnering meetings while taking in the breathtaking views of the world-famous Torrey Pines Golf Course at our Gala Networking Reception on the outdoor lawn. Often hailed as the highlight of the conference, this evening reception promises great company, delicious bites and a fully hosted cocktail and mocktail bar ensuring everyone can raise a glass to success. Friendly Reminder: While San Diego is known for its great weather, please prepare to be outside as colder weather is anticipated.
February 26, 2026
Conference registration will remain open throughout the entirety of the conference.
We invite you to join us for a networking breakfast before our first session of the day. We encourage you to arrive by 8:00 a.m. to ensure you get a seat in time for the sessions kicking off at 8:15 a.m.
Biocom’s Global Partnering & Investor Conference utilizes partneringONE to facilitate one-on-one meetings between conference attendees. The partnering system is now open. Approved registrants can update their profiles, identify potential partners and request meetings with fellow attendees.
Michael Bellin
Deals Partner & U.S. IPO Services Leader, PwC
Mira Chaurushiya, Ph.D.
Managing Director, Westlake Village BioPartners
Benjamin Chen, Ph.D.
Partner, Panacea Venture
Jon Edwards, Ph.D.
Partner, Forbion
Tomotaka Goji, Ph.D.
Co-Founder, Managing Partner, CEO, President & Representative Director, The University of Tokyo Edge Capital Partners
Deborah Palestrant, Ph.D.
Partner & Executive Chair, 4:59 Initiative, 5AM Ventures
Ben Cravatt, Ph.D.
Professor & Gilula Chair, Chemical Biology, The Scripps Research Institute
James Fraser, Ph.D.
Professor & Chair, Department of Bioengineering and Therapeutic Sciences, California Institute of Quantitative Biosciences, UC San Francisco
Richard Heyman, Ph.D.
Venture Partner, ARCH Ventures
Richard Tillyer, Ph.D.
Global Head, Discovery, Product Development & Supply, Johnson & Johnson Innovative Medicine
This can’t-miss conversation will touch on the areas of innovation that are generating the greatest interest, the role of AI in accelerating drug discovery and development, how biotech companies can most effectively work with large pharmaceutical companies and more.
Jay Bradner, M.D.
Executive Vice President, Research & Development, Amgen
Steven Paul, M.D.
Board Chair, FNIH; Venture Partner, Third Rock Ventures
Jonathon Sedgwick, Ph.D.
Senior Vice President & Global Head, Discovery Research, AbbVie
Daniel Skovronsky, M.D., Ph.D.
Chief Scientific & Product Officer; President, Lilly Research Laboratories, Eli Lilly
Stephen Abreu
Partner, Cooley
Grace Han McMahon
AVP and Head, Pacific BD&L, Merck
Avi Spier, Ph.D.
Executive Director, Search & Evaluation, Novartis
Tari Suprapto, Ph.D.
Senior Director, Head of Search, Novo Nordisk
Adrianne Wong, Ph.D.
Senior Director, Oncology Search & Evaluation, Global Business Development, Daiichi Sankyo
Racquel Bracken
General Partner, Venrock
Jeremy Caldwell, Ph.D.
Managing Director, Red Tree Venture Capital
Jay Lichter, Ph.D.
Managing Director, Avalon Ventures
Carolyn Ng, Ph.D.
Partner & Managing Director, TPG Life Sciences Innovations
Jason Skolnik
Corporate Partner, Wilson Sonsini
Michael Yee
Global Head of Biotechnology Research & Senior Pharma and Biotech Analyst, UBS
Join us for complimentary drinks and hors d’oeuvres immediately following the closing session of the conference. Don’t miss the opportunity to make those last connections with attendees and speakers before leaving sunny San Diego.